Click a link below to view the mailing archive as if it had been sent to you.
| 2015-06-30 12:15 | | Samsung and Biogen plot an IPO for their biosimilars JV and more... |
| 2015-06-30 00:15 | | Johnson & Johnson's New Drug Invega Trinza Will Help Drive Pharma Sales and more... |
| 2015-06-29 12:15 | | FDA is Sued by Advocacy Groups That Want Gilead Hepatitis C Trial Data and more... |
| 2015-06-28 12:15 | | The Biotech Drug Lord: How One Man Is Conquering The Biotech Space and more... |
| 2015-06-28 00:15 | | Acquisitions May Fuel Gilead Sciences' Winning Ways and more... |
| 2015-06-27 12:15 | | Take your medicine: CA lawmakers approve mandatory vax bill for children and more... |
| 2015-06-27 00:15 | | How Novartis' CEO wants to tackle an ever-aging world and more... |
| 2015-06-26 12:15 | | Celladon pulls the plug on R&D after a crushing gene therapy failure and more... |
| 2015-06-25 12:15 | | Report: It pays big to focus on diabetes drugs and more... |
| 2015-06-25 00:15 | | U.S. CDC committee recommends physicians make individual decisions on the use of meningococcal group B vaccines and more... |
| 2015-06-24 12:15 | | AbbVie hepatitis C cocktail succeeds in late-stage study and more... |
| 2015-06-24 00:15 | | Call it Allergan, call it a 'growth pharma.' Just don't call it Big Pharma and more... |
| 2015-06-23 12:15 | | Emerging markets still beat elsewhere for Big Pharma growth, with AstraZeneca in the lead and more... |
| 2015-06-23 00:15 | | Pharma ad budgets to dip in 2016, but J&J, Pfizer, Roche and Novartis should still top $2B and more... |
| 2015-06-22 12:15 | | Biotechs line up for a busy week of IPOs and more... |
| 2015-06-22 00:15 | | China Rejects Gilead's Sovaldi Patent Application and more... |
| 2015-06-20 12:15 | | Novartis exec: Pharma culture can be stumbling block to creativity and more... |
| 2015-06-20 00:15 | | Bristol-Myers' Opdivo is approved as a skin cancer treatment in Europe and more... |
| 2015-06-19 12:15 | | Amicus briefs pile up in Amarin lawsuit and more... |
| 2015-06-19 00:15 | | Generic Drugs Should Look Similar to the Drugs They Reference, FDA Says and more... |
| 2015-06-18 12:15 | | Despite insider sale, Receptos stock surges on takeover rumors and more... |
| 2015-06-18 00:15 | | What Allergan Is Looking to Add With Kythera and more... |
| 2015-06-17 12:15 | | FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market and more... |
| 2015-06-17 00:15 | | Three Companies with the Ingredients to Follow in the Footsteps of Advaxis and more... |
| 2015-06-16 12:15 | | Pulmatrix hits Wall Street with $10M and a Mylan deal and more... |
| 2015-06-16 00:15 | | Teva Announces FDA Acceptance of the Biologics License Application for Reslizumab and more... |
| 2015-06-15 12:15 | | FirstWord Lists – The biggest drug approvals of 2015 and more... |
| 2015-06-15 00:15 | | How Often Are Drugs Withdrawn For Safety or Effectiveness Reasons (and How Many)? Not Too Often in Recent Years, But There is a Tranche of Withdrawals Historically and more... |
| 2015-06-13 12:15 | | What You May Have Missed in Biotech: Cholesterol Drug Scrutiny and a Hedge Fund Alzheimer's Play and more... |
| 2015-06-13 00:15 | | GSK deal keeps paying off for Novartis with more positive Arzerra data and more... |
| 2015-06-12 12:15 | | AZ chief med officer abruptly quits, CEO Soriot to oversee late-stage R&D and more... |
| 2015-06-12 00:15 | | Pfizer Trial of Antidepressant Pristiq on Children Fails to Meet Goal and more... |
| 2015-06-11 12:15 | | J&J's global hunt for new drugs, cool new tech spurs 17 new deals and more... |
| 2015-06-11 00:15 | | Is This Johnson & Johnson's Next Blockbuster? and more... |
| 2015-06-10 12:15 | | Biosim war heats up as Merck's Remicade & Enbrel biosimilars bag major wins in RA and more... |
| 2015-06-10 00:15 | | GSK asthma medication to go before FDA panel Thursday and more... |
| 2015-06-09 12:15 | | Canadians hope $250 mln trial can revive failed Roche heart drug and more... |
| 2015-06-09 00:15 | | Giant Study Boosts Januvia, Merck's $6 Billion Drug and more... |
| 2015-06-08 12:15 | | Swedish Orphan Plunges After Talks End on Potential Takeover and more... |
| 2015-06-07 12:15 | | New Mega-Blockbuster Cholesterol Drug Class Faces Make-or-Break FDA Panels and more... |
| 2015-06-06 00:15 | | Top-Performing Biotech and Drug Stocks During ASCO '15 and more... |
| 2015-06-05 12:15 | | Gilead Sciences: What Game Theory Teaches Us About Hepatitis C and more... |
| 2015-06-05 00:15 | | Merck's Quest To Revive The Market For Insomnia Drugs and more... |
| 2015-06-04 12:15 | | Active Biotech axes 84% of staff in retreat from R&D and more... |
| 2015-06-04 00:15 | | Return of the Scarlet Letter? AbbVie Petitions FDA to Require Biosimilar Labeling to Include Disclaimers and a Description of Data Differences and more... |
| 2015-06-03 12:15 | | AZ's Soriot lashes out at U.K.'s refusal to pay for first-in-class cancer drug and more... |
| 2015-06-03 00:15 | | Juno stock pops 15 percent after $44M acquisition of Boston-area biotech and more... |
| 2015-06-02 12:15 | | 16 Biotech Stocks Moving Off The ASCO Conference and more... |
| 2015-06-02 00:15 | | The Biggest Selling Cancer Drugs In 2020 Show Significant Change Expected In Five Short Years and more... |
| 2015-06-01 12:15 | | 6 Key Cancer Winners From ASCO Presentations and more... |
